Retinal haemodynamics in individuals with well-controlled type 1 diabetes

被引:37
作者
Lorenzi, M. [1 ,2 ]
Feke, G. T. [3 ]
Cagliero, E. [4 ,5 ]
Pitler, L. [1 ,2 ]
Schaumberg, D. A. [6 ,7 ]
Berisha, F. [3 ]
Nathan, D. M. [4 ,5 ]
McMeel, J. W. [3 ]
机构
[1] Harvard Univ, Sch Med, Schepens Eye Res Inst, Boston, MA 02115 USA
[2] Harvard Univ, Sch Med, Dept Ophthalmol, Boston, MA 02115 USA
[3] Harvard Univ, Sch Med, Schepens Retina Assoc Fdn, Boston, MA 02115 USA
[4] Harvard Univ, Sch Med, Massachusetts Gen Hosp, Ctr Diabet, Boston, MA 02115 USA
[5] Harvard Univ, Sch Med, Massachusetts Gen Hosp, Dept Med, Boston, MA 02115 USA
[6] Harvard Univ, Sch Med, Div Prevent Med, Boston, MA 02115 USA
[7] Harvard Univ, Sch Med, Brigham & Womens Hosp, Dept Med, Boston, MA 02115 USA
关键词
diabetic retinopathy; retinal blood flow; retinal circulation; type; 1; diabetes;
D O I
10.1007/s00125-007-0872-0
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Aims/hypothesis Abnormalities in retinal haemodynamics have been reported in patients with type 1 diabetes in advance of clinical retinopathy. These abnormalities could therefore be useful as early markers or surrogate endpoints for studying the microangiopathy. Since the DCCT, the increased focus on good glycaemic control is changing the natural history of diabetic retinopathy. Based on this, the aim of this study was to investigate whether patients with type 1 diabetes treated entirely or mostly in the post-DCCT era and tested in the absence of confounding factors show retinal haemodynamic abnormalities. Methods We measured retinal haemodynamics by laser Doppler flowmetry in 33 type 1 diabetic individuals with no or minimal retinopathy (age 30 +/- 7 years, duration of diabetes 8.8 +/- 4.6 years, 9% showing microaneurysms), and 31 age- and sex-matched non-diabetic controls. The study participants were not taking vasoactive medications, and blood glucose at the time of haemodynamic measurements was required to be between 3.8 and 11.1 mmol/l. Results HbA(1c) was 7.5 +/- 1.2% and blood glucose 7.7 +/- 2.8 mmol/l in these type 1 diabetic individuals, indicating relatively good glycaemic control. Retinal blood speed, arterial diameter and blood flow were not different between the diabetic individuals and the matched controls. Conclusions/interpretation Type 1 diabetic patients with no or minimal retinopathy who maintain relatively good glycaemic control do not show abnormalities of the retinal circulation at steady state, even after several years of diabetes. In such patients it may be necessary to test the vascular response to challenges to uncover any subtle abnormalities of the retinal vessels.
引用
收藏
页码:361 / 364
页数:4
相关论文
共 10 条
[1]  
Bursell SE, 1996, INVEST OPHTH VIS SCI, V37, P886
[2]   Vascular endothelial growth factor and severity of nonproliferative diabetic retinopathy mediate retinal hemodynamics in vivo: A potential role for vascular endothelial growth factor in the progression of nonproliferative diabetic retinopathy [J].
Clermont, AC ;
Aiello, LP ;
Mori, F ;
Aiello, LM ;
Bursell, SE .
AMERICAN JOURNAL OF OPHTHALMOLOGY, 1997, 124 (04) :433-446
[3]  
FEKE GT, 1994, INVEST OPHTH VIS SCI, V35, P2968
[4]   Retinal arteriolar diameter, blood velocity, and blood flow response to an isocapnic hyperoxic provocation in early sight-threatening diabetic retinopathy [J].
Gilmore, Edward D. ;
Hudson, Chris ;
Nrusimhadevara, Ravi K. ;
Harvey, Patricia T. ;
Mandelcorn, Mark ;
Lam, Wai Ching ;
Devenyi, Robert G. .
INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2007, 48 (04) :1744-1750
[5]   Retinal Hemodynamics in early diabetic macular edema [J].
Guan, K ;
Hudson, C ;
Wong, T ;
Kisilevsky, M ;
Nrusimhadevara, RK ;
Lam, WC ;
Mandelcorn, M ;
Devenyi, RG ;
Flanagan, JG .
DIABETES, 2006, 55 (03) :813-818
[6]   IMPAIRED RETINAL ARTERY BLOOD-FLOW IN IDDM PATIENTS BEFORE CLINICAL MANIFESTATIONS OF DIABETIC-RETINOPATHY [J].
KAWAGISHI, T ;
NISHIZAWA, Y ;
EMOTO, M ;
KONISHI, T ;
MAEKAWA, K ;
HAGIWARA, S ;
OKUNO, Y ;
INADA, H ;
ISSHIKI, G ;
MORII, H .
DIABETES CARE, 1995, 18 (12) :1544-1549
[7]   THE EFFECT OF INTENSIVE TREATMENT OF DIABETES ON THE DEVELOPMENT AND PROGRESSION OF LONG-TERM COMPLICATIONS IN INSULIN-DEPENDENT DIABETES-MELLITUS [J].
SHAMOON, H ;
DUFFY, H ;
FLEISCHER, N ;
ENGEL, S ;
SAENGER, P ;
STRELZYN, M ;
LITWAK, M ;
WYLIEROSETT, J ;
FARKASH, A ;
GEIGER, D ;
ENGEL, H ;
FLEISCHMAN, J ;
POMPI, D ;
GINSBERG, N ;
GLOVER, M ;
BRISMAN, M ;
WALKER, E ;
THOMASHUNIS, A ;
GONZALEZ, J ;
GENUTH, S ;
BROWN, E ;
DAHMS, W ;
PUGSLEY, P ;
MAYER, L ;
KERR, D ;
LANDAU, B ;
SINGERMAN, L ;
RICE, T ;
NOVAK, M ;
SMITHBREWER, S ;
MCCONNELL, J ;
DROTAR, D ;
WOODS, D ;
KATIRGI, B ;
LITVENE, M ;
BROWN, C ;
LUSK, M ;
CAMPBELL, R ;
LACKAYE, M ;
RICHARDSON, M ;
LEVY, B ;
CHANG, S ;
HEINHEINEMANN, M ;
BARRON, S ;
ASTOR, L ;
LEBECK, D ;
BRILLON, D ;
DIAMOND, B ;
VASILASDWOSKIN, A ;
LAURENZI, B .
NEW ENGLAND JOURNAL OF MEDICINE, 1993, 329 (14) :977-986
[8]   Early supernormal retinal oxygenation response in patients with diabetes [J].
Trick, GL ;
Edwards, P ;
Desai, U ;
Berkowitz, BA .
INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2006, 47 (04) :1612-1619
[9]  
WOLF S, 1991, OPHTHALMOLOGY, V98, P996
[10]   Reproducibility and clinical application of a newly developed stabilized retinal laser Doppler instrument [J].
Yoshida, A ;
Feke, GT ;
Mori, F ;
Nagaoka, T ;
Fujio, N ;
Ogasawara, H ;
Konno, S ;
McMeel, JW .
AMERICAN JOURNAL OF OPHTHALMOLOGY, 2003, 135 (03) :356-361